David Saxon

Q: What is David Saxon's success rate?

David Saxon currently has a success rate of 92.91819422194206.

Q: What is the average return of David Saxon's calls?

Their stock ratings have generated an average return of 24.598540580318335.

Needham | Healthcare

David Saxon is an analyst from Needham specializing in the Healthcare sector. Ranked #970 out of 4773 analysts, they have issued 39 stock ratings with a success rate of 92.92% and an average return of 24.60%.

David Saxon has a well-established track record, with 39 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 92.92% and an average return of 24.60%, underscoring their expertise and ability to identify winning opportunities for investors.

#970

Out of 4773

Total Ratings

+92.92%

Success Rate

+24.60%

Average Return

Recent Ratings Analysis

AZTA

Buy

Aug 05, 2026

Target

$37.00

Current

$30.85

Performance

-3.05%

David Saxon rated AZTA as Buy on Aug 05, 2026, setting a price target of 37. Shares have remained stable near 30.85, leaving the 37 target still in play.

GKOS

Buy

Jul 30, 2026

Target

$201.00

Current

$167.25

Performance

-0.75%

On Jul 30, 2026, GKOS was given a Buy rating by David Saxon, with a target price of 201. The stock traded sideways with a -0.75% move, keeping the bullish thesis unresolved.

RXST

Buy

Jul 07, 2026

Target

$11.00

Current

$6.02

Performance

7.12%

RXST received a Buy rating from David Saxon on Jul 07, 2026, aiming for 11. Momentum has favored the Buy call, with shares climbing from 6.02 to 6.02, rewarding those who trusted the recommendation.

CARL

Buy

Jul 01, 2026

Target

$17.00

Current

$14.73

Performance

25.79%

On Jul 01, 2026, David Saxon published a Buy outlook on CARL, with a target of 17. Shares gained 25.79%, underscoring the accuracy of the bullish outlook toward 17.

COO

Buy

Jun 05, 2026

Target

$86.00

Current

$53.91

Performance

-19.94%

David Saxon on Jun 05, 2026 assigned COO a Buy rating, with a price target of 86. The call has struggled to gain traction, with shares losing 19.94%.

GMED

Buy

May 08, 2026

Target

$117.00

Current

$74.19

Performance

-4.82%

On May 08, 2026, David Saxon reaffirmed GMED with a Buy rating, targeting 117. Market indecision has kept the 117 target in a holding pattern.

ATEC

Buy

May 06, 2026

Target

$14.00

Current

$10.58

Performance

51.36%

ATEC was rated Buy by David Saxon on May 06, 2026, with a price objective of 14. A bullish response from the market helped close the gap of 3.42 to the target.

ALC

Buy

May 06, 2026

Target

$100.00

Current

$66.03

Performance

0.95%

On May 06, 2026, David Saxon initiated coverage on ALC with a Buy rating and target of 100. Neutral price movement of 0.95% leaves room for interpretation.

CYRX

Buy

May 05, 2026

Target

$15.00

Current

$15.55

Performance

27.56%

David Saxon issued a Buy recommendation for CYRX on May 05, 2026, price target set at 15. Investors following the Buy call captured upside momentum, with shares now at 15.55.

IRTC

Buy

May 01, 2026

Target

$255.00

Current

$111.43

Performance

—

On May 01, 2026, IRTC was evaluated by David Saxon, who gave a Buy rating and target of 255. So far, the Buy call awaits clearer momentum, with shares flat at 111.43.

SIBN

Buy

Dec 16, 2025

Target

$27.00

Current

$18.38

Performance

-5.36%

David Saxon rated SIBN as Buy on Dec 16, 2025, setting a price target of 27. The stock has underperformed, dropping 5.36% despite the bullish target of 27.

XRAY

Hold

Sep 26, 2025

Target

—

Current

$10.46

Performance

-16.32%

On Sep 26, 2025, XRAY was given a Hold rating by David Saxon, with a target price of null. The rating provided protection from downside risk as the stock fell to 10.46.

SGHT

Hold

Aug 28, 2025

Target

—

Current

$8.14

Performance

101.49%

SGHT received a Hold rating from David Saxon on Aug 28, 2025, aiming for null. Investors saw gains of 101.49% that the cautious stance didn’t fully capture.

ZIMV

Hold

Apr 09, 2025

Target

—

Current

$18.99

Performance

97.81%

On Apr 09, 2025, David Saxon published a Hold outlook on ZIMV, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

NVST

Hold

Mar 06, 2025

Target

—

Current

$25.55

Performance

43.30%

David Saxon on Mar 06, 2025 assigned NVST a Hold rating, with a price target of null. Shares outperformed expectations, climbing 43.30% despite the neutral view.

STAA

Hold

Feb 27, 2025

Target

—

Current

$22.66

Performance

28.09%

On Feb 27, 2025, David Saxon reaffirmed STAA with a Hold rating, targeting null. Market strength beyond 22.66 went further than the conservative outlook suggested.

BLCO

Hold

Feb 20, 2025

Target

—

Current

$17.25

Performance

8.56%

BLCO was rated Hold by David Saxon on Feb 20, 2025, with a price objective of null. Despite caution, upside momentum rewarded risk-takers with gains to 17.25.

ALGN

Hold

Feb 06, 2025

Target

—

Current

$150.82

Performance

-30.94%

On Feb 06, 2025, David Saxon initiated coverage on ALGN with a Hold rating and target of null. The rating matched the stock’s inability to hold above 150.82.

Frequency Asked Questions

Who is David Saxon?

David Saxon is an analyst from Needham specializing in the Healthcare sector.

What is David Saxon's success rate?

David Saxon currently has a success rate of +92.92%.

How many ratings has David Saxon issued?

David Saxon has issued 39 stock ratings so far.

What is the average return of David Saxon's calls?

Their stock ratings have generated an average return of +24.60%.

What is David Saxon's ranking?

David Saxon is ranked #970 out of 4773 analysts.

What types of ratings does David Saxon give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Saxon?

You can follow David Saxon by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Saxon?

Their latest rating was a Buy on AZTA issued on 2026-08-05.